977. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme is subject to any formal fraud-risk assessment, expenditure-risk scoring, or internal audit programme specific to high-cost referrals. [36573/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Healthcare Policy.
247 questions match, newest first.
978. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has carried out any benchmarking comparing the cost of overseas treatments funded under the treatment abroad scheme against equivalent domestic provision or alternative care pathways. [36575/26]
979. Deputy Ken O'Flynn asked the Minister for Health whether any external clinical advisory body or independent review panel exists for disputed or high-cost treatment abroad scheme applications. [36576/26]
980. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or her Department maintains any database, framework, or internal assessment comparing the average cost of treatments funded under the treatment abroad scheme across different jurisdictions. [36578/26]
981. Deputy Ken O'Flynn asked the Minister for Health whether any analysis has been carried out on whether equivalent procedures funded under the treatment abroad scheme could be accessed at lower cost in alternative jurisdictions within the EU, UK or Switzerland. [36579/26]
982. Deputy Ken O'Flynn asked the Minister for Health whether any formal value-for-money methodology applies when approving treatment locations under the treatment abroad scheme. [36580/26]
983. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive records the total reimbursement cost by treatment type and jurisdiction under the treatment abroad scheme. [36581/26]
984. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, financial review, or governance assessment has examined variations in treatment abroad scheme reimbursement costs between jurisdictions for comparable procedures. [36582/26]
985. Deputy Ken O'Flynn asked the Minister for Health whether any maximum reimbursement thresholds, indicative cost bands, or comparative pricing references are used when assessing applications under the Treatment Abroad Scheme. [36583/26]
986. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive has identified any jurisdictions with materially higher reimbursement costs under the treatment abroad scheme for equivalent procedures. [36584/26]
996. Deputy Ken O'Flynn asked the Minister for Health the total expenditure incurred under the treatment abroad scheme in relation to referrals of minors for gender-related assessment or treatment abroad in each year since 2020. [36601/26]
997. Deputy Ken O'Flynn asked the Minister for Health whether any formal written policy, clinical governance framework, or risk assessment governs referrals of minors abroad for gender-related healthcare; and if she will provide details. [36602/26]
998. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken any independent review of outcomes, safeguarding issues, regret rates, detransition rates, or long-term psychological outcomes associated with referrals of minors abroad for gender-related healthcare.; and if she will make a statement on the matter. [36603/26]
999. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the implications of the final Cass Review for Irish clinical practice regarding minors referred abroad for gender-related healthcare. [36604/26]
1000. Deputy Ken O'Flynn asked the Minister for Health whether any pause, restriction, or revised clinical threshold was considered following publication of the Cass Review in relation to referrals of minors abroad for gender-related healthcare. [36605/26]
1001. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has issued updated clinical guidance to GPs, consultant paediatricians, psychiatrists, or CAMHS teams concerning referrals of minors for gender-related healthcare abroad following changes introduced by the NHS in September 2024. [36606/26]
1003. Deputy Ken O'Flynn asked the Minister for Health whether any Irish clinicians currently participate in multidisciplinary assessment processes connected to overseas gender-related healthcare referrals for minors. [36608/26]
1004. Deputy Ken O'Flynn asked the Minister for Health whether the updated Irish gender healthcare model of care will include a national audit framework, outcomes monitoring system, detransition support pathway, and safeguarding review mechanism for minors. [36609/26]
1010. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or her Department intends to introduce a formal national obesity-attributable disease modelling framework for Ireland; the proposed timeline for same; and if she will make a statement on the matter. [36641/26]
1011. Deputy Ken O'Flynn asked the Minister for Health whether any national cost-of-illness study is currently underway regarding obesity-related disease expenditure across the health service; and if she will make a statement on the matter. [36642/26]
1012. Deputy Ken O'Flynn asked the Minister for Health whether the HSE centrally measures the proportion of hospital admissions attributable to obesity-related conditions; and if not, whether there are plans to introduce such measurement systems. [36643/26]
1014. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been carried out regarding the projected impact of obesity-related disease on future acute hospital capacity demand and workforce requirements to 2035. [36645/26]
1015. Deputy Ken O'Flynn asked the Minister for Health whether obesity-related disease expenditure is separately identifiable within the HSE budgeting process; and if not, whether this has been identified as a strategic planning weakness. [36646/26]
1016. Deputy Ken O'Flynn asked the Minister for Health whether the Department has assessed the long-term economic impact of childhood obesity trends on future healthcare expenditure and labour-force participation. [36647/26]
1090. Deputy Ken O'Flynn asked the Minister for Health the projected total cost of the National Laboratory Information System (MedLIS) rollout to completion in 2029; the expenditure incurred to date; and if she will make a statement on the matter. [36995/26]